SCHEMBL29935183

SCHEMBL29935183

Cc1ccc(S(=O)(=O)n2cc(I)c3cc(Cl)nnc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.39
POLB P06746 1/20 0.39
ALDH3A1 P30838 1/20 0.39
HTT P42858 1/20 0.39
NOD1 Q9Y239 1/20 0.39
ALDH1A1 P00352 1/20 0.38
RAPGEF4 Q8WZA2 1/20 0.38
KDM4E B2RXH2 1/20 0.38
UBE2N P61088 1/20 0.38
PKM P14618 1/20 0.37
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KLK7 P49862 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24722820 0.87 BRD4 (0.48) BRD4ALDH3A1HTTALDH1A1MEN1
SCHEMBL19250520 0.85 CA1 (0.47) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL30461664 0.82 ALDH1A1 (0.43) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL25419377 0.82 ALDH1A1 (0.43) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL30399721 0.81 HPGD (0.42) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL26176367 0.81 HPGD (0.42) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL18995268 0.81 BRD4 (0.51) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL31150811 0.81 BRD4 (0.51) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL19250316 0.79 BRD4 (0.54) BRD4L3MBTL1POLBALDH3A1HTT
SCHEMBL12066672 0.76 BRD4 (0.51) BRD4L3MBTL1POLBALDH3A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115073472-A Condensed bicyclic compound, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2022-09-20 CN disclosed